+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995396
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cardiac Marker Testing Market size was estimated at USD 5.10 billion in 2023, USD 5.50 billion in 2024, and is expected to grow at a CAGR of 7.90% to reach USD 8.69 billion by 2030.

Cardiac marker testing market consists of the spectrum of medical technologies and services that revolve around the usage of biomarkers for the diagnosis and management of cardiovascular diseases. The prevalence of cardiovascular diseases and need for effective diagnostics has increased the adoption of cardiac markers worldwide. The rise of point-of-care testing for cardiac markers has significantly increased the screening of cardiovascular diseases. The initiatives encouraging early cardiovascular disease detection have also contributed to market growth. However, the incidences of product recalls of cardiac marker testing solutions may limit its market adoption. The concerns associated with inaccuracy and limited specificity of cardiac market testing are also challenging factors for the market growth. Moreover, the advancements in testing technologies and the integration of new biomarkers are creating attractive opportunities in the market. Increasing consumer preference towards personalized medicine and the introduction of tailored cardiac marker testing are expected to witness significant growth in upcoming years.

Regional Insights

In the Americas region, the cardiac marker testing market has been flourishing with advancements in technology and the escalating prevalence of cardiovascular diseases. Several local companies and start-ups in major countries such as the United States, Canada, and Brazil, have been focusing on developing and introducing cost-effective and portable devices for effective cardiac assessment. In the Europe region, the cardiac marker testing market has been extensively driven by the increasing number of cardiovascular diseases, the aging population, and the well-established healthcare infrastructure. The cardiac marker testing market in the Middle East and Africa has been significantly impacted due to the rising awareness about coronary people diseases and the expansion of healthcare services. Cardiac marker testing market has been growing at an accelerated rate in APAC countries including China, India, and Japan due to the surge in healthcare services and the significant presence of major companies. The government support in terms of investments for healthcare research and development has led to an increase in innovations in cardiac testing methods.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Marker Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Marker Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Assure Tech (Hangzhou) Co., Ltd., Atlas Medical GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biomérieux SA, Boditech Med Inc., Charles River Laboratories International, Inc., Cleerly, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche AG, HyTest Ltd., Laboratory Corporation of America Holdings, LightDeck Diagnostics, Merck KGaA, Natera, Inc., PerkinElmer Inc., Qiagen N.V., Quest Diagnostics, QuidelOrtho Corporation, Randox Laboratories Ltd., Sekbio, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
      • Chemiluminescence
      • ELISA
      • Immunochromatography
      • Immunofluorescence
    • Reagents & Kits
  • Biomarker
    • BNP Or NT-ProBNP
    • Ceratine Kinase-MB
    • hs-CRP
    • Myoglobin
    • Troponin
  • Type of Testing
    • Laboratory Testing
    • Point-Of-Care Testing
  • Disease
    • Congestive Heart Failure
    • Myocardial Infarction
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Cardiac Marker Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Marker Testing Market?
  3. What are the technology trends and regulatory frameworks in the Cardiac Marker Testing Market?
  4. What is the market share of the leading vendors in the Cardiac Marker Testing Market?
  5. Which modes and strategic moves are suitable for entering the Cardiac Marker Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cardiac Marker Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of cardiovascular diseases and need for effective diagnostics
5.1.1.2. Rise of point-of-care testing for cardiac markers worldwide
5.1.1.3. Initiatives encouraging early detection and screening of cardiovascular diseases
5.1.2. Restraints
5.1.2.1. Adverse recalls of cardiac marker testing products
5.1.3. Opportunities
5.1.3.1. Advancements in testing technologies and integration of new biomarkers
5.1.3.2. Shift toward personalized medicine and introduction of tailored cardiac marker testing
5.1.4. Challenges
5.1.4.1. Concerns associated with inaccuracy and limited specificity of cardiac marker testing
5.2. Market Segmentation Analysis
5.2.1. Product: Significance of diagnostic instruments in cardiac marker testing
5.2.2. Biomarker: Rising utilization of Troponin biomarker for cardiac assessment
5.2.3. Type of Testing: Increasing adoption of Point-of-Care testing
5.2.4. Disease: Extensive applications of cardiac marker testing in myocardial infarction
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cardiac Marker Testing Market, by Product
6.1. Introduction
6.2. Instruments
6.3.1. Chemiluminescence
6.3.2. ELISA
6.3.3. Immunochromatography
6.3.4. Immunofluorescence
6.3. Reagents & Kits
7. Cardiac Marker Testing Market, by Biomarker
7.1. Introduction
7.2. BNP Or NT-ProBNP
7.3. Ceratine Kinase-MB
7.4. hs-CRP
7.5. Myoglobin
7.6. Troponin
8. Cardiac Marker Testing Market, by Type of Testing
8.1. Introduction
8.2. Laboratory Testing
8.3. Point-Of-Care Testing
9. Cardiac Marker Testing Market, by Disease
9.1. Introduction
9.2. Congestive Heart Failure
9.3. Myocardial Infarction
10. Americas Cardiac Marker Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cardiac Marker Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cardiac Marker Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. NOWDx and AeenaDx Announce Merger
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Pathkind Labs, Roche Diagnostics Partner to Release Cardiac Biomarker
13.3.3. New Product Launch & Enhancement
13.3.3.1. Mindray Expands Cardiac Biomarker Portfolio with Launch of New Assays
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Agilent Technologies, Inc.
14.1.3. Assure Tech (Hangzhou) Co., Ltd.
14.1.4. Atlas Medical GmbH
14.1.5. Becton, Dickinson and Company
14.1.6. Bio-Rad Laboratories, Inc.
14.1.7. Bio-Techne Corporation
14.1.8. Biomérieux SA
14.1.9. Boditech Med Inc.
14.1.10. Charles River Laboratories International, Inc.
14.1.11. Cleerly, Inc.
14.1.12. Danaher Corporation
14.1.13. DiaSorin S.p.A.
14.1.14. Eurofins Scientific SE
14.1.15. F. Hoffmann-La Roche AG
14.1.16. HyTest Ltd.
14.1.17. Laboratory Corporation of America Holdings
14.1.18. LightDeck Diagnostics
14.1.19. Merck KGaA
14.1.20. Natera, Inc.
14.1.21. PerkinElmer Inc.
14.1.22. Qiagen N.V.
14.1.23. Quest Diagnostics
14.1.24. QuidelOrtho Corporation
14.1.25. Randox Laboratories Ltd.
14.1.26. Sekbio
14.1.27. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
14.1.28. Siemens Healthineers AG
14.1.29. Thermo Fisher Scientific Inc.
14.1.30. Tosoh Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. CARDIAC MARKER TESTING MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC MARKER TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. CARDIAC MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC MARKER TESTING MARKET DYNAMICS
FIGURE 7. CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2023 VS 2030 (%)
FIGURE 10. CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2023 VS 2030 (%)
FIGURE 12. CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 14. CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CARDIAC MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. CARDIAC MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CARDIAC MARKER TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CARDIAC MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 8. CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 14. CARDIAC MARKER TESTING MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CARDIAC MARKER TESTING MARKET SIZE, BY CERATINE KINASE-MB, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CARDIAC MARKER TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 20. CARDIAC MARKER TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CARDIAC MARKER TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 23. CARDIAC MARKER TESTING MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CARDIAC MARKER TESTING MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 41. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 43. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 44. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 45. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 68. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 70. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 71. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 72. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 73. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 75. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 76. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 77. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 115. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 136. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 141. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 159. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 162. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 163. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 179. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 181. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 182. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 183. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 184. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 186. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 187. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 188. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 234. CARDIAC MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 235. CARDIAC MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 236. CARDIAC MARKER TESTING MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Assure Tech (Hangzhou) Co., Ltd.
  • Atlas Medical GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biomérieux SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Cleerly, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • HyTest Ltd.
  • Laboratory Corporation of America Holdings
  • LightDeck Diagnostics
  • Merck KGaA
  • Natera, Inc.
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Sekbio
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation

Methodology

Loading
LOADING...

Table Information